JCVI minimal cell (syn3.0 and syn3A)

What it is

The JCVI minimal cell is the result of asking how few genes a free-living cell can carry. JCVI-syn3.0, derived from Mycoplasma mycoides subspecies capri, carries about 473 genes and is described as the simplest bacterium capable of autonomous growth in axenic, that is pure, culture.^[1] It is a synthetic-genome organism: the chromosome was designed, built and installed rather than edited gene by gene, which makes it a sibling project to genome writing in yeast and bacteria.^[5][6]

syn3.0 versus syn3A

Minimality came at a cost. JCVI-syn3A, the strain most laboratories actually use, encodes 19 non-essential genes that syn3.0 lacks; it divides like a normal bacterial cell and is not as fragile as syn3.0.^[2] The pair therefore functions as a controlled experiment in robustness: what you get back when you return a small number of genes to a stripped genome.

The strain family

The strains form a graded series rather than a single organism. JCVI-syn1.0 is a near-wild-type Mycoplasma mycoides subspecies capri strain carrying a synthetic genome; JCVI-syn3.0 is the most minimised version, with an unusual division phenotype, fragile and not easily handled in many laboratory operations.^[7] JCVI-syn3A restores 19 non-essential genes and divides normally.^[2] JCVI-syn3B is JCVI-syn3A plus a dual loxP landing pad, which makes Cre recombinase-mediated insertion of new genes straightforward, so it is the version to reach for when the point is to add pathways rather than to study minimality.^[8]

That engineering handle is where the applications sit. Reported work on JCVI-syn3B includes using it to understand persistent pathogens and exploring it as an anticancer therapeutic, alongside efforts to build genome-scale algorithms for understanding and manipulating cellular functions.^[9] These are conference reports rather than published results, so they are recorded here as reported.

Why researchers use it

A minimal genome means fewer confounding genes, which makes the strain attractive as a chassis for measuring how cellular systems interact and as a reference for whole-cell modelling. More than 90 research groups have used or studied the minimal cell and related strains since the 2016 publication.^[3] For circuit work, a simplified host reduces the number of unknown interactions a design has to survive, although fast iteration usually still happens in cell-free extracts.^[10]

What is still unknown

Minimal does not mean understood. Workshop proceedings published in June 2025 record genes that remain unannotated yet matter, including a quasi-essential transaldolase required for the cell to reach a two-hour doubling time.^[4] That is the central scientific interest of the strain: the residual biology that cannot be removed and cannot yet be explained.

What it is used for

Three uses dominate. As a reference organism it lets researchers ask which functions are genuinely indispensable, because a 473-gene cell leaves little redundancy to hide behind.^[1] As a modelling target its short parts list makes whole-cell description tractable in a way a full bacterium is not.^[3] And as a chassis it offers a host with few competing pathways, at the cost of fragility, which is the trade-off syn3A was built to soften.^[2]

Workshop proceedings published in June 2025 give the clearest picture of the community around these strains and of the biology still unresolved in them.^[3][4] The fourth Minimal Cell Workshop, an international virtual seminar drawing on more than 80 academic, industrial and government laboratories, ran 26 talks covering super-resolution imaging and cryotomography, DNA replication assays, cell division, ATP synthesis and moonlighting proteins.^[11] The spread of topics is itself informative: with only about 473 genes, the open questions are about mechanism rather than gene discovery.^[1]

How it fits the field

The minimal cell anchors the “read the whole system” end of synthetic biology, while recoding projects such as the four-megabase Syn57 Escherichia coli genome anchor the “rewrite the whole system” end.^[6][12] Both rely on the same industrial base of synthetic DNA, which now ships at a rate of hundreds of thousands of genes per quarter from a single supplier.^[13]